 |
ARICEPT NEWS |
| ||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||
| DO YOU HAVE ALZHEIMERS? |
||||||||||||||||||||||||||||
| "DR. REYES... IS CLOSE TO FINDING A CURE....HE NEEDS YOUR HELP: YOU CAN HELP WIN THE FINAL BATTLE FOR A CURE BY JOINING A TRIAL!".... Stan Swartz, CEO, The MD Health Channel |
||||||||||||||||||||||||||||
 "You'll receive all medication and study based procedures at no charge if you qualify for one of the many trials being conducted at Barrow Neurological Institute." |
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
| 4 TALES OF NEUROSURGERY & A PIANO CONCERT BY DR. SPETZLER... Plus 2 books written by Survivors for Survivors! |
||||||||||||||||||||||||||||
 |
||||||||||||||||||||||||||||
| Robert F. Spetzler M.D. Director, Barrow Neurological Institute J.N. Harber Chairman of Neurological Surgery Professor Section of Neurosurgery University of Arizona |
||||||||||||||||||||||||||||
| TALES OF NEUROSURGERY: | ||||||||||||||||||||||||||||
A pregnant mother..a baby..faith of a husband.. .plus... Cardiac Standstill: cooling the patient to 15 degrees Centigrade! |
||||||||||||||||||||||||||||
| Lou Grubb Anurism |
||||||||||||||||||||||||||||
| The young Heros - kids who are confronted with significant medical problems! |
||||||||||||||||||||||||||||
| 2 Patients...confronted with enormous decisions before their surgery...wrote these books to help others! |
||||||||||||||||||||||||||||
| A 1 MINUTE PIANO CONCERT BY DR. SPETZLER |
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
| Links | ||||||||||||||||||||||||||||
| Barrow Neurological Institute | ||||||||||||||||||||||||||||
| Archives | ||||||||||||||||||||||||||||
| April 2006 | ||||||||||||||||||||||||||||
| August 2006 | ||||||||||||||||||||||||||||
Saturday
Written by Pharmacists Reviewed by Doctors:
GENERIC NAME: donepezil
BRAND NAME: Aricept, Aricept ODT
DRUG CLASS AND MECHANISM: Donepezil is an oral medication used to treat Alzheimer's disease. It belongs to a class of drugs called cholinesterase inhibitors that also includes tacrine (Cognex). Scientists believe that Alzheimer's disease may result from a deficiency in chemicals (neurotransmitters) used by nerves in the brain to communicate with one another. Donepezil inhibits acetylcholinesterase, an enzyme responsible for the destruction of one neurotransmitter, acetylcholine. This leads to increased concentrations of acetylcholine in the brain, and the increased concentrations are believed to be responsible for the improvement seen during treatment with donepezil. Donepezil improves the symptoms but does not slow down the progression of Alzheimer's disease. Donepezil was approved by the FDA in 1996.
PRESCRIPTION: yes
GENERIC AVAILABLE: no
PREPARATIONS: Aricept is available in 5 and 10 mg tablets. Aricept ODT (orally disintegrating tablets) also are available in 5 and 10 mg tablets.
STORAGE: Tablets should be stored at room temperature, 15-30°C (59-86°F).
PRESCRIBED FOR: Donepezil is used for the treatment of mild to moderate dementia of the Alzheimer's type.
DOSING: Donepezil is generally taken once daily at night prior to retiring. Its absorption is not affected by food so that it may be taken with or without food.
DRUG INTERACTIONS: Drugs with anti-cholinergic properties that can cross into the brain, such as atropine, benztropine (Cogentin), and trihexyphenidyl (Artane) counteract the effects of donepezil and should be avoided during therapy with donepezil.
Donepezil is metabolized (eliminated) by enzymes in the liver. The rate of metabolism of donepezil may be increased by medications that increase the amounts of these enzymes, such as carbamazepine (Tegretol), dexamethasone (Decadron), phenobarbital, phenytoin (Dilantin), and rifampin (Rifadin). By increasing elimination, these drugs may reduce the effects of donepezil.
Ketoconazole (Nizoral) has been shown to block the enzymes in the liver that metabolize donepezil. Therefore, concurrent use of ketoconazole and donepezil may result in increased concentrations of donepezil in the body and possibly lead to donepezil side effects. Quinidine (Quinidex, Quinaglute) also has been shown to inhibit the enzymes that metabolize donepezil and may cause donepezil side effects.
PREGNANCY: It is not known whether donepezil is harmful to the fetus. Safe use during pregnancy has not been established.
NURSING MOTHERS: It is not known whether the donepezil is secreted into breast milk or if breast-feeding while taking donepezil is safe for the nursing infant.
SIDE EFFECTS: The most frequently reported side effects associated with donepezil include headache, generalized pain, fatigue, dizziness, nausea, vomiting, diarrhea, loss of appetite, weight loss, muscle cramping, joint pain, insomnia, and increased frequency of urination.
Tacrine (Cognex), another anticholinesterase medication used in the treatment of Alzheimer's disease, is associated with liver toxicity. Donepezil does not appear to be associated with liver toxicity.
GENERIC NAME: donepezil
BRAND NAME: Aricept, Aricept ODT
DRUG CLASS AND MECHANISM: Donepezil is an oral medication used to treat Alzheimer's disease. It belongs to a class of drugs called cholinesterase inhibitors that also includes tacrine (Cognex). Scientists believe that Alzheimer's disease may result from a deficiency in chemicals (neurotransmitters) used by nerves in the brain to communicate with one another. Donepezil inhibits acetylcholinesterase, an enzyme responsible for the destruction of one neurotransmitter, acetylcholine. This leads to increased concentrations of acetylcholine in the brain, and the increased concentrations are believed to be responsible for the improvement seen during treatment with donepezil. Donepezil improves the symptoms but does not slow down the progression of Alzheimer's disease. Donepezil was approved by the FDA in 1996.
PRESCRIPTION: yes
GENERIC AVAILABLE: no
PREPARATIONS: Aricept is available in 5 and 10 mg tablets. Aricept ODT (orally disintegrating tablets) also are available in 5 and 10 mg tablets.
STORAGE: Tablets should be stored at room temperature, 15-30°C (59-86°F).
PRESCRIBED FOR: Donepezil is used for the treatment of mild to moderate dementia of the Alzheimer's type.
DOSING: Donepezil is generally taken once daily at night prior to retiring. Its absorption is not affected by food so that it may be taken with or without food.
DRUG INTERACTIONS: Drugs with anti-cholinergic properties that can cross into the brain, such as atropine, benztropine (Cogentin), and trihexyphenidyl (Artane) counteract the effects of donepezil and should be avoided during therapy with donepezil.
Donepezil is metabolized (eliminated) by enzymes in the liver. The rate of metabolism of donepezil may be increased by medications that increase the amounts of these enzymes, such as carbamazepine (Tegretol), dexamethasone (Decadron), phenobarbital, phenytoin (Dilantin), and rifampin (Rifadin). By increasing elimination, these drugs may reduce the effects of donepezil.
Ketoconazole (Nizoral) has been shown to block the enzymes in the liver that metabolize donepezil. Therefore, concurrent use of ketoconazole and donepezil may result in increased concentrations of donepezil in the body and possibly lead to donepezil side effects. Quinidine (Quinidex, Quinaglute) also has been shown to inhibit the enzymes that metabolize donepezil and may cause donepezil side effects.
PREGNANCY: It is not known whether donepezil is harmful to the fetus. Safe use during pregnancy has not been established.
NURSING MOTHERS: It is not known whether the donepezil is secreted into breast milk or if breast-feeding while taking donepezil is safe for the nursing infant.
SIDE EFFECTS: The most frequently reported side effects associated with donepezil include headache, generalized pain, fatigue, dizziness, nausea, vomiting, diarrhea, loss of appetite, weight loss, muscle cramping, joint pain, insomnia, and increased frequency of urination.
Tacrine (Cognex), another anticholinesterase medication used in the treatment of Alzheimer's disease, is associated with liver toxicity. Donepezil does not appear to be associated with liver toxicity.